146 related articles for article (PubMed ID: 38555633)
1. Association of Sevelamer Initiation with Gastrointestinal Bleeding Hospitalization in Individuals Requiring Hemodialysis.
Le D; Crews DC; Grams ME; Coresh J; Shin JI
Am J Nephrol; 2024 Mar; ():. PubMed ID: 38555633
[TBL] [Abstract][Full Text] [Related]
2. A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data.
St Peter WL; Liu J; Weinhandl E; Fan Q
Am J Kidney Dis; 2008 Mar; 51(3):445-54. PubMed ID: 18295060
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Outcomes of Calcium-Free vs Calcium-Based Phosphate Binders in Patients 65 Years or Older With End-stage Renal Disease Requiring Hemodialysis.
Spoendlin J; Paik JM; Tsacogianis T; Kim SC; Schneeweiss S; Desai RJ
JAMA Intern Med; 2019 Jun; 179(6):741-749. PubMed ID: 31058913
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of calcium acetate and sevelamer on clinical outcomes in elderly hemodialysis patients enrolled in Medicare part D.
Yusuf AA; Weinhandl ED; St Peter WL
Am J Kidney Dis; 2014 Jul; 64(1):95-103. PubMed ID: 24387795
[TBL] [Abstract][Full Text] [Related]
5. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
Ruospo M; Palmer SC; Natale P; Craig JC; Vecchio M; Elder GJ; Strippoli GF
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006023. PubMed ID: 30132304
[TBL] [Abstract][Full Text] [Related]
6. Initiation of Sevelamer and Mortality among Hemodialysis Patients Treated with Calcium-Based Phosphate Binders.
Komaba H; Wang M; Taniguchi M; Yamamoto S; Nomura T; Schaubel DE; Smith AR; Zee J; Karaboyas A; Bieber B; Fukagawa M; Tentori F
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1489-1497. PubMed ID: 28724618
[TBL] [Abstract][Full Text] [Related]
7. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients.
Block GA; Raggi P; Bellasi A; Kooienga L; Spiegel DM
Kidney Int; 2007 Mar; 71(5):438-41. PubMed ID: 17200680
[TBL] [Abstract][Full Text] [Related]
8. Effect of Calcium-based Phosphate Binders Versus Sevelamer on Mortality of Patients with Hemodialysis: A Meta-analysis.
Zhang P; Sang S; Huang J; Feng S; Feng C; Wang R
Iran J Kidney Dis; 2022 Jul; 16(4):215-227. PubMed ID: 35962636
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of morbidity and mortality data related to cardiovascular calcification from calcium-containing phosphate binder use in patients undergoing hemodialysis.
Mason MA; Shepler BM
Pharmacotherapy; 2010 Jul; 30(7):741-8. PubMed ID: 20575637
[TBL] [Abstract][Full Text] [Related]
10. Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
Navaneethan SD; Palmer SC; Craig JC; Elder GJ; Strippoli GF
Am J Kidney Dis; 2009 Oct; 54(4):619-37. PubMed ID: 19692157
[TBL] [Abstract][Full Text] [Related]
11. Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial.
Garg JP; Chasan-Taber S; Blair A; Plone M; Bommer J; Raggi P; Chertow GM
Arthritis Rheum; 2005 Jan; 52(1):290-5. PubMed ID: 15641045
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of sevelamer versus calcium-based phosphate binders in hemodialysis patients: a secondary analysis using centers for Medicare & Medicaid services data.
St Peter WL; Fan Q; Weinhandl E; Liu J
Clin J Am Soc Nephrol; 2009 Dec; 4(12):1954-61. PubMed ID: 19833904
[TBL] [Abstract][Full Text] [Related]
13. Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials.
Patel L; Bernard LM; Elder GJ
Clin J Am Soc Nephrol; 2016 Feb; 11(2):232-44. PubMed ID: 26668024
[TBL] [Abstract][Full Text] [Related]
14. Update and critical appraisal of sevelamer in the management of chronic renal failure.
Grinfeld J; Inaba A; Hutchison AJ
Open Access J Urol; 2010 Sep; 2():161-70. PubMed ID: 24198624
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis.
Habbous S; Przech S; Acedillo R; Sarma S; Garg AX; Martin J
Nephrol Dial Transplant; 2017 Jan; 32(1):111-125. PubMed ID: 27651467
[TBL] [Abstract][Full Text] [Related]
16. Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial.
Di Iorio B; Molony D; Bell C; Cucciniello E; Bellizzi V; Russo D; Bellasi A;
Am J Kidney Dis; 2013 Oct; 62(4):771-8. PubMed ID: 23684755
[TBL] [Abstract][Full Text] [Related]
17. Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients.
Shantouf R; Budoff MJ; Ahmadi N; Tiano J; Flores F; Kalantar-Zadeh K
Am J Nephrol; 2008; 28(2):275-9. PubMed ID: 17992011
[TBL] [Abstract][Full Text] [Related]
18. Sevelamer Use and Mortality in People with Chronic Kidney Disease Stages 4 and 5 Not on Dialysis.
Molina P; Molina MD; Carrero JJ; Escudero V; Torralba J; Castro-Alonso C; Beltrán S; Vizcaíno B; González-Moya M; Kanter J; Sancho-Calabuig A; Bover J; Górriz JL
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137700
[No Abstract] [Full Text] [Related]
19. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients: results of a randomized clinical trial.
Suki WN;
J Ren Nutr; 2008 Jan; 18(1):91-8. PubMed ID: 18089452
[TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis.
Sekercioglu N; Thabane L; Díaz Martínez JP; Nesrallah G; Longo CJ; Busse JW; Akhtar-Danesh N; Agarwal A; Al-Khalifah R; Iorio A; Guyatt GH
PLoS One; 2016; 11(6):e0156891. PubMed ID: 27276077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
